212 results on '"Cherif, Honar"'
Search Results
2. Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP)
3. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
4. Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
5. Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review.
6. Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes.
7. Cancer risk in patients with primary immune thrombocytopenia – A Swedish nationwide register study
8. Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region.
9. Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group
10. Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
11. Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East.
12. Post-Thymectomy Autoimmune Flare-Up With New-Onset Type 1 Diabetes Mellitus.
13. Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group.
14. Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
15. Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region
16. Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
17. CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
18. MDS-569 Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients With Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region
19. POSTER: MDS-569 Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients With Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region
20. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group
21. Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up
22. Next‐generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial
23. Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia
24. Recurrent sideroblastic anemia during pregnancy
25. Central catheter-related Gordonia bronchialis bacteremia in an immunocompromised patient: A case report, and literature review
26. Differentiation syndrome in patients with acute promyelocytic leukemia
27. Clinicopathologic Characteristics and Outcome of Acute Myeloid Leukemia with (AML) with Core Binding Factor (CBF) Rearrangements: A Retrospective Study
28. Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML): A Single Center Experience
29. A Comparative Study between Acute Myeloid Leukemia in Adolescent and Young Adults (AYA) Versus Non-AYA Patients: Single Center Experience
30. Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP)
31. Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
32. Differentiation Syndrome In Patients With Acute Promyelocytic Leukemia
33. Peri-Renal Extramedullary Hematopoiesis in Primary Myelofibrosis Patient.
34. Recurrent sideroblastic anaemia during pregnancy
35. Sickle Cell Disease in Sweden - Prevalence and Resource Use Estimated through Population-Based National Registers
36. Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region
37. Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis : an observational study
38. A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine
39. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication
40. Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study
41. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients
42. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases
43. Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
44. Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients
45. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
46. Surveillance of Triazole Susceptibility of Colonizing Yeasts in Patients with Haematological Malignancies
47. A Prospective, Randomized Study Comparing Cefepime and Imipenem-Cilastatin in the Empirical Treatment of Febrile Neutropenia in Patients Treated for Haematological Malignancies
48. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler’s Disease, Uppsala University Hospital
49. Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study
50. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.